Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001221231-03-000017
Filing Date
2003-10-01
Accepted
2003-10-01 17:44:52
Documents
1
Period of Report
2003-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4312
  Complete submission text file 0001221231-03-000017.txt   6109
Mailing Address XOMA CORP /DE/ 2910 SEVENTH ST BERKLEY CA 94710
Business Address 2910 SEVENTH ST BERKELEY CA 94710 5106441170
XOMA LTD /DE/ (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 942756657 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA, LTD. 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
DAVIS PETER B (Reporting) CIK: 0001222789 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 03921728